Literature DB >> 20816379

Angiotensin-receptor blockade, cancer, and concerns.

Stevo Julius, Sverre E Kjeldsen, Michael A Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20816379     DOI： 10.1016/S1470-2045(10)70159-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Angiotensin receptor blockers and the risk of malignancy: a note of caution.

Authors:  Domenic A Sica
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 2.  Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials.

Authors:  Magnus Baumhäkel; Michael Böhm
Journal:  Vasc Health Risk Manag       Date:  2011-06-23

Review 3.  Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk.

Authors:  Csaba Farsang
Journal:  Vasc Health Risk Manag       Date:  2011-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.